FDA NDC Directory · JSON-LD · Markdown

OZEMPIC

NDC 50090-6051 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namesemaglutide
Labeler / ManufacturerA-S Medication Solutions
Marketing categoryNew Drug Application (innovator) · App NDA209637
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsSEMAGLUTIDE (2.68 mg/mL)
Marketing started20220425
Package count1

External sources

Source: openFDA. Public-domain (CC0).